en
Scientific article
Open access
English

HIV-1 exploits CCR5 conformational heterogeneity to escape inhibition by chemokines

Publication date2013
Abstract

CC chemokine receptor 5 (CCR5) is a receptor for chemokines and the coreceptor for R5 HIV-1 entry into CD4(+) T lymphocytes. Chemokines exert anti-HIV-1 activity in vitro, both by displacing the viral envelope glycoprotein gp120 from binding to CCR5 and by promoting CCR5 endocytosis, suggesting that they play a protective role in HIV infection. However, we showed here that different CCR5 conformations at the cell surface are differentially engaged by chemokines and gp120, making chemokines weaker inhibitors of HIV infection than would be expected from their binding affinity constants for CCR5. These distinct CCR5 conformations rely on CCR5 coupling to nucleotide-free G proteins ((NF)G proteins). Whereas native CCR5 chemokines bind with subnanomolar affinity to (NF)G protein-coupled CCR5, gp120/HIV-1 does not discriminate between (NF)G protein-coupled and uncoupled CCR5. Interestingly, the antiviral activity of chemokines is G protein independent, suggesting that "low-chemokine affinity" (NF)G protein-uncoupled conformations of CCR5 represent a portal for viral entry. Furthermore, chemokines are weak inducers of CCR5 endocytosis, as is revealed by EC50 values for chemokine-mediated endocytosis reflecting their low-affinity constant value for (NF)G protein-uncoupled CCR5. Abolishing CCR5 interaction with (NF)G proteins eliminates high-affinity binding of CCR5 chemokines but preserves receptor endocytosis, indicating that chemokines preferentially endocytose low-affinity receptors. Finally, we evidenced that chemokine analogs achieve highly potent HIV-1 inhibition due to high-affinity interactions with internalizing and/or gp120-binding receptors. These data are consistent with HIV-1 evading chemokine inhibition by exploiting CCR5 conformational heterogeneity, shed light into the inhibitory mechanisms of anti-HIV-1 chemokine analogs, and provide insights for the development of unique anti-HIV molecules.

Keywords
  • CD4-Positive T-Lymphocytes/metabolism
  • Cell Line
  • Chemokines/metabolism
  • Endocytosis/physiology
  • HIV Infections/metabolism/physiopathology
  • HIV-1/metabolism/physiology
  • Humans
  • Protein Conformation
  • Radioligand Assay
  • Receptors, CCR5/chemistry/metabolism
  • Virus Internalization
Research group
Citation (ISO format)
COLIN, Philippe et al. HIV-1 exploits CCR5 conformational heterogeneity to escape inhibition by chemokines. In: Proceedings of the National Academy of Sciences of the United States of America, 2013, vol. 110, n° 23, p. 9475–9480. doi: 10.1073/pnas.1222205110
Main files (1)
Article (Published version)
accessLevelPublic
Identifiers
ISSN of the journal0027-8424
559views
253downloads

Technical informations

Creation12/10/2014 11:16:00 AM
First validation12/10/2014 11:16:00 AM
Update time03/14/2023 10:25:09 PM
Status update03/14/2023 10:25:08 PM
Last indexation01/16/2024 3:05:55 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack